Individualizing Optimal Dosing of Antithymocyte Globulin in Allogeneic Hematopoietic Cell Transplantation

被引:2
作者
Hashmi, Shahrukh K. [1 ,2 ]
机构
[1] Mayo Clin, Dept Med, Div Hematol, 200 1st St SW, Rochester, MN 55905 USA
[2] King Faisal Specialist Hosp & Res Ctr, Oncol Ctr, Riyadh, Saudi Arabia
关键词
Transplant; ATG; Lymphocyte; VERSUS-HOST-DISEASE; HEMATOLOGICAL MALIGNANCIES; UNRELATED DONORS; OPEN-LABEL; MULTICENTER; PHASE-3;
D O I
10.1016/j.bbmt.2017.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2 / 3
页数:2
相关论文
共 9 条
[1]   Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research [J].
Arai, Sally ;
Arora, Mukta ;
Wang, Tao ;
Spellman, Stephen R. ;
He, Wensheng ;
Courie, Daniel R. ;
Urbano-Ispizua, Alvaro ;
Cutler, Corey S. ;
Bacigalupo, Andrea A. ;
Battiwallaw, Minoo ;
Flowers, Mary E. ;
Juckett, Mark B. ;
Lee, Stephanie J. ;
Loren, Alison W. ;
Klumpp, Thomas R. ;
Prockup, Susan E. ;
Ringden, Olle E. T. H. ;
Savani, Bipin N. ;
Socie, Gerard ;
Schultz, Kirk R. ;
Spitzer, Thomas ;
Teshima, Takanori ;
Bredeson, Christopher N. ;
Jacobsohn, David A. ;
Hayashi, Robert J. ;
Drobyski, William R. ;
Frangoul, Haydar A. ;
Akpek, Gorgiin ;
Ho, Vincent T. ;
Lewis, Victor A. ;
Gale, Robert Peter ;
Koreth, John ;
Chao, Nelson J. ;
Aljurf, Mahmoud D. ;
Cooper, Brenda W. ;
Laughlin, Mary J. ;
Hsu, Jack W. ;
Hematti, Peiman ;
Verdonck, Leo F. ;
Solh, Melhelm M. ;
Norkin, Maxim ;
Reddy, Vijay ;
Perez-Simon, Jose A. ;
Khera, Nandita ;
Lewis, Ian D. ;
Atsuta, Yoshiko ;
Olsson, Richard F. ;
Saber, Wael ;
Waller, Edmund K. ;
Blaise, Didier .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) :266-274
[2]   Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: Long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation [J].
Bacigalupo, A ;
Lamparelli, T ;
Barisione, G ;
Bruzzi, P ;
Guidi, S ;
Alessandrino, PE ;
di Bartolomeo, P ;
Oneto, R ;
Bruno, B ;
Sacchi, N ;
van Lint, MT ;
Bosi, A .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (05) :560-565
[3]   Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial [J].
Finke, Juergen ;
Schmoor, Claudia ;
Bethge, Wolfgang Andreas ;
Ottinger, Hellmut ;
Stelljes, Matthias ;
Volin, Liisa ;
Heim, Dominik ;
Bertz, Hartmut ;
Grishina, Olga ;
Socie, Gerard .
LANCET HAEMATOLOGY, 2017, 4 (06) :E293-E301
[4]   Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count [J].
Kennedy, Vanessa E. ;
Chen, Heidi ;
Savani, Bipin N. ;
Greer, John ;
Kassim, Adetola A. ;
Engelhardt, Brian G. ;
Goodman, Stacey ;
Sengsayadeth, Salyka ;
Chinratanalab, Wichai ;
Jagasia, Madan .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) :150-155
[5]   Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease [J].
Kroeger, Nicolaus ;
Solano, Carlos ;
Wolschke, Christine ;
Bandini, Giuseppe ;
Patriarca, Francesca ;
Pini, Massimo ;
Nagler, Arnon ;
Selleri, Carmine ;
Risitano, Antonio ;
Messina, Giuseppe ;
Bethge, Wolfgang ;
Perez de Oteiza, Jaime ;
Duarte, Rafael ;
Carella, Angelo Michele ;
Cimminiello, Michele ;
Guidi, Stefano ;
Finke, Juergen ;
Mordini, Nicola ;
Ferra, Christelle ;
Sierra, Jorge ;
Russo, Domenico ;
Petrini, Mario ;
Milone, Giuseppe ;
Benedetti, Fabio ;
Heinzelmann, Marion ;
Pastore, Domenico ;
Jurado, Manuel ;
Terruzzi, Elisabetta ;
Narni, Franco ;
Voelp, Andreas ;
Ayuk, Francis ;
Ruutu, Tapani ;
Bonifazi, Francesca .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (01) :43-53
[6]   Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial [J].
Locatelli, Franco ;
Bernardo, Maria Ester ;
Bertaina, Alice ;
Rognoni, Carla ;
Comoli, Patrizia ;
Rovelli, Attilio ;
Pession, Andrea ;
Fagioli, Franca ;
Favre, Claudio ;
Lanino, Edoardo ;
Giorgiani, Giovanna ;
Merli, Pietro ;
Pagliara, Daria ;
Prete, Arcangelo ;
Zecca, Marco .
LANCET ONCOLOGY, 2017, 18 (08) :1126-1136
[7]  
Robert J, 2016, BLOOD, V128, P505
[8]   Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial [J].
Walker, Irwin ;
Panzarella, Tony ;
Couban, Stephen ;
Couture, Felix ;
Devins, Gerald ;
Elemary, Mohamed ;
Gallagher, Genevieve ;
Kerr, Holly ;
Kuruvilla, John ;
Lee, Stephanie J. ;
Moore, John ;
Nevill, Thomas ;
Popradi, Gizelle ;
Roy, Jean ;
Schultz, Kirk R. ;
Szwajcer, David ;
Toze, Cynthia ;
Foley, Ronan .
LANCET ONCOLOGY, 2016, 17 (02) :164-173
[9]   Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation [J].
Wingard, John R. ;
Majhail, Navneet S. ;
Brazauskas, Ruta ;
Wang, Zhiwei ;
Sobocinski, Kathleen A. ;
Jacobsohn, David ;
Sorror, Mohamed L. ;
Horowitz, Mary M. ;
Bolwell, Brian ;
Rizzo, J. Douglas ;
Socie, Gerard .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) :2230-2239